Leuthold Group, LLC Medpace Holdings, Inc. Transaction History

Leuthold Group, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$138.87 - $214.31 $306,624 - $473,196	-2,208 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$182.74 - $227.9 $4,568 - $5,697	-25 Reduced 1.12%	2,208 $481,000
Q2 2021 Aug 13, 2021	SELL	$158.62 - $194.3 $9,675 - $11,852	-61 Reduced 2.66%	2,233 $394,000
Q1 2021 May 17, 2021	SELL	$132.02 - $168.26 $7,525 - $9,590	-57 Reduced 2.42%	2,294 $376,000
Q4 2020 Feb 16, 2021	SELL	$109.38 - $149.19 $2.64 Million - $3.61 Million	-24,165 Reduced 91.13%	2,351 $327,000
Q3 2020 Nov 16, 2020	SELL	$92.95 - $130.61 $26,397 - $37,093	-284 Reduced 1.06%	26,516 $2.96 Million
Q2 2020 Aug 14, 2020	BUY	$68.08 - $95.68 $1.82 Million - $2.56 Million	26,800 New	26,800 $2.49 Million
Q4 2019 Feb 14, 2020	SELL	$70.08 - $84.64 $503,735 - $608,392	-7,188 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$62.38 - $85.89 $23,018 - $31,693	-369 Reduced 4.88%	7,188 $604,000
Q2 2019 Aug 14, 2019	SELL	$53.64 - $65.42 $73,164 - $89,232	-1,364 Reduced 15.29%	7,557 $494,000
Q1 2019 May 15, 2019	SELL	$49.38 - $70.58 $24,936 - $35,642	-505 Reduced 5.36%	8,921 $526,000
Q4 2018 Feb 14, 2019	BUY	$46.97 - $63.98 $442,739 - $603,075	9,426 New	9,426 $499,000

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Leuthold Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Leuthold Group, LLC with notifications on news.